Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2008 |
The purpose of this study is to assess the IOP-lowering efficacy of a combination of
Travoprost / Timolol maleate, dosed in the morning or in the evening, in patients with
open-angle glaucoma or ocular hypertension, who have an insufficiently controlled IOP
(mmHg), and are using prostaglandin analogue monotherapy.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
